DossierENTITY

US investment restrictions

Coverage of US investment restrictions in the Nexus archive.

Earliest in view: Jun 30 · 03:00 UTCMost recent: Jun 30 · 03:00 UTC

Co-mentioned in this coverage

the world’s largest buyer of biopharmaceutical royaltiesorganization1 Hong Kongplace1 mainland Chinese biotechnology firmsorganization1 royalty financingtopic1 multinational corporationsorganization1 Pharmaceutical Sectortopic1

Recent coverage

BUSINESSJun 30 · 03:00 UTCSCMP CHINA
Funding option: royalties giant opens Hong Kong base as mainland China biotech deals surge
The world’s largest biopharmaceutical royalties buyer has established its first Asia-Pacific base in Hong Kong as mainland Chinese biotech firms drive record out-licensing deals. Royalty financing is highlighted as an alternative capital-raising method amid US investment restrictions.

US investment restrictions · Dossier · The Nexus